Challenger Limited

CGF

AU000000CGF5

Life & Health Insurance

Market Closed - Australian S.E. Other stock markets 07:10:50 17/07/2024 BST			5-day change	1st Jan Change
6.99 ^AUD	+0.58%		+2.95%	+7.70%

05-22	Challenger Extends Reinsurance Partnership Agreement with Mitsui Sumitomo Primary Life Insurance	MT
04-30	Heartland Group Completes Challenger Bank Acquisition	MT

Challenger Limited Announces Appointment of Richard Howes as Director

January 09, 2019 at 06:33 am

Challenger Limited announced the appointment of Richard Howes as director of the company, effective 2 January 2019.

Latest news about Challenger Limited

Challenger Extends Reinsurance Partnership Agreement with Mitsui Sumitomo Primary Life Insurance	05-22	MT
Heartland Group Completes Challenger Bank Acquisition	04-30	MT
Heartland Group to Complete Challenger Bank Acquisition on Tuesday After Regulatory Approvals	04-29	MT
Challenger's Assets Under Management Rise 6% in Fiscal Q3; Upgrades Guidance	04-18	MT
New Zealand Shares Decline on Monday; Heartland Group Secures Regulatory Approvals to Acquire Challenger Bank	04-08	MT
Heartland Group Receives Regulatory Approvals for Challenger Bank Acquisition; Begins NZ$210 Million Raise	04-07	MT
Jarden Research Adjusts Challenger Limited’s Price Target to AU$7.55 From AU$7.25, Keeps at Overweight	02-14	MT
Transcript : Challenger Limited, H1 2024 Earnings Call, Feb 13, 2024	02-12
Challenger Posts 80% Jump in Fiscal H1 Net Profit	02-12	MT
Challenger Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-12	CI
Challenger Limited Declares Interim Dividend for the Six Months Ended 31 December 2023, Payable on 19 March 2024	02-12	CI
Transcript : Challenger Limited - Special Call	11-30
Challenger Limited Announces Quarterly Dividend of One Quarter Ended February 25, 2024, Payable on February 26, 2024	11-29	CI
Challenger Limited Announces Quarterly Dividend Ended February 26, 2024, Payable on February 25, 2024	11-29	CI
Challenger Expands Relationship with Apollo Global Management	11-09	MT
Challenger Limited Appoints Matthew Michelini as Director	11-09	CI
Challenger Limited and Challenger Life Company Limited Announce the Appointment of Lisa Gray as Independent Non-Executive Director, Effective 9 November 2023	11-08	CI
Transcript : Challenger Limited - Shareholder/Analyst Call	25/10/23
Challenger Limited Announces Board Changes	26/09/23	CI
Challenger Limited Declares Ordinary Dividend for the Six Months Period Ended 30 June 2023, Payable on 20 September 2023	14/09/23	CI
Challenger Raises Final Dividend as Fiscal 2023 Profit Grows; Shares Fall 6%	15/08/23	MT
Transcript : Challenger Limited, 2023 Earnings Call, Aug 15, 2023	15/08/23
Challenger Limited Reports Earnings Results for the Full Year Ended June 30, 2023	14/08/23	CI
Challenger Limited Declares Dividend for the Six Months Period Ended 30 June 2023, Payable on September 20, 2023	14/08/23	CI
Challenger to Provide De-Risking Service for Aware Super's Fund	26/07/23	MT

Challenger Limited is an Australia-based investment management company. The Company operates through two segments: Life and Funds Management. The Life segment principally includes the annuity and life insurance business carried out by Challenger Life Company (CLC). CLC offers fixed-rate and other retirement and superannuation products that are designed for Australian investors who are seeking a low-risk, fixed-term, or lifetime investment and reliable income. CLC also offers fixed-term and lifetime investments to investors in Japan through its reinsurance arrangement with Mitsui Sumitomo Primary Life Insurance Company Limited (MS Primary). CLC invests in assets that provide long-term income streams for customers. Its Funds Management segment is engaged in providing an end-to-end fund management business. The Funds Management segment also offers a range of managed investments across fixed income and property.

Sector

Life & Health Insurance

Calendar

12/08/2024 - Q4 2024 Earnings Release

Related indices

S&P/ASX 200

More about the company

Income Statement Evolution

More financial data

Ratings for Challenger Limited

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

6.99 AUD

Average target price

7.591 AUD

Spread / Average Target

+8.60%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Life Insurance

	1st Jan change	Capi.
CHALLENGER LIMITED	+7.70%	3.2B
CHINA LIFE INSURANCE COMPANY LIMITED	+9.88%	99.77B
PING AN INSURANCE (GROUP) COMPANY OF CHINA, LTD.	+4.94%	92.98B
LIFE INSURANCE CORPORATION OF INDIA	+33.15%	83.9B
AIA GROUP LIMITED	-19.84%	75.99B
FUBON FINANCIAL HOLDING CO., LTD.	+40.43%	36.55B
JAPAN POST HOLDINGS CO., LTD.	+32.16%	33.67B
SBI LIFE INSURANCE COMPANY LIMITED	+13.18%	19.43B
HDFC LIFE INSURANCE COMPANY LIMITED	+0.01%	16.65B
NN GROUP N.V.	+26.91%	13.47B

Life Insurance